A DOUBLE-BLIND, PLACEBO-CONTROLLED, study to EVALUATE the EFFICACY and safety of 24 weeks treatment with REN001 in patients with primary mitochondrial myopathy (PMM)
A DOUBLE-BLIND, PLACEBO-CONTROLLED, study to EVALUATE the EFFICACY and safety of 24 weeks treatment with REN001 in patients with primary mitochondrial myopathy (PMM)